NYMX - Nymox Pharmaceutical receives potential delisting notice from Nasdaq

2023-07-06 04:15:37 ET

• Nymox Pharmaceutical ( NASDAQ: NYMX ) informed shareholders on Wednesday that it has received a delisting determination letter from Nasdaq on failing to regain with the minimum bid price requirement.
• The deadline to regain compliance with Nasdaq listing requirements was July 3, 2023.
• The company's shares will be suspended from trading on Nasdaq at the open of business on July 7, 2023.
• The company said its common stock will be quoted on the OTC Markets after delisting from Nasdaq.
• Shares of NYMX are down 14.3% in premarket trade on Thursday.

For further details see: